"Coronary Restenosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Recurrent narrowing or constriction of a coronary artery following surgical procedures performed to alleviate a prior obstruction.
| Descriptor ID |
D023903
|
| MeSH Number(s) |
C14.280.647.250.285.200 C14.907.585.250.285.200
|
| Concept/Terms |
Coronary Restenosis- Coronary Restenosis
- Coronary Restenoses
- Restenoses, Coronary
- Restenosis, Coronary
|
Below are MeSH descriptors whose meaning is more general than "Coronary Restenosis".
Below are MeSH descriptors whose meaning is more specific than "Coronary Restenosis".
This graph shows the total number of publications written about "Coronary Restenosis" by people in this website by year, and whether "Coronary Restenosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 1 | 2 | 3 |
| 2003 | 1 | 0 | 1 |
| 2004 | 5 | 0 | 5 |
| 2005 | 2 | 0 | 2 |
| 2007 | 1 | 0 | 1 |
| 2008 | 2 | 0 | 2 |
| 2009 | 1 | 1 | 2 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 2 | 4 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 3 | 5 |
| 2017 | 26 | 11 | 37 |
| 2018 | 34 | 6 | 40 |
| 2019 | 7 | 2 | 9 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Coronary Restenosis" by people in Profiles.
-
Quantitative flow ratio for functional evaluation of in-stent restenosis. EuroIntervention. 2021 Aug 06; 17(5):e396-e398.
-
In-stent restenosis characteristics and repeat stenting underexpansion: insights from optical coherence tomography. EuroIntervention. 2020 07 17; 16(4):e335-e343.
-
Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study. EuroIntervention. 2019 Dec 06; 15(11):e1022-e1024.
-
Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circ Cardiovasc Interv. 2019 08; 12(8):e007023.
-
Absorb Bioresorbable Scaffold Versus Xience Metallic Stent for Prevention of Restenosis Following Percutaneous Coronary Intervention in Patients at High Risk of Restenosis: Rationale and Design of the COMPARE ABSORB Trial. Cardiovasc Revasc Med. 2019 Jul; 20(7):577-582.
-
Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother. 2019 04 01; 5(2):105-116.
-
Daily risk of adverse outcomes in patients undergoing complex lesions revascularization: A subgroup analysis from the RAIN-CARDIOGROUP VII study (veRy thin stents for patients with left mAIn or bifurcatioN in real life). Int J Cardiol. 2019 09 01; 290:64-69.
-
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study. Cardiovasc Diabetol. 2019 03 04; 18(1):24.
-
In-stent restenosis associated with dual-layer Roadsaver carotid artery stent: a retrospective single-center study. Radiol Med. 2019 Jul; 124(7):704-709.
-
Dual antiplatelet therapy in acute coronary syndrome after stent implantation: How short is short and how long is long? Hellenic J Cardiol. 2018 Nov - Dec; 59(6):376-377.